Missed primary end point but not a throw away project. Value in treatment is obviously there. So since the news is not as bad as expected, there is shorters last chance is get out is completely blown. LOL, I saw a few attempts at a large scary SELL order which got blown out with a 1.3M volume buy. I think that sent the signal that there are no sellers who will give their shares away at these prices.
Expect a few sh*tty articles from the AFR highlighting the missed primary end point but anyone left holding here has balls of steel and so the soft retail hands will not help the shorters. I expect there are some instos that finally feel comfortable enough to buy in with all the main P3 results out for a medium term hold.
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-110
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |